Stealth and Cunning: Hepatitis B and Hepatitis C Viruses

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2005 Jul 15

PMID 16014900

Citations 190

Authors

Stefan F Wieland

Francis V Chisari

Affiliations

Soon will be listed here.

Citing Articles

From the Cytoplasm into the Nucleus-Hepatitis B Virus Travel and Genome Repair.

Ringlander J, Rydell G, Kann M Microorganisms. 2025; 13(1.

PMID: 39858925 PMC: 11767736. DOI: 10.3390/microorganisms13010157.

Tissue Determinants of Antiviral Immunity in the Liver.

Wohlleber D, Knolle P Z Gastroenterol. 2025; 63(1):65-72.

PMID: 39793603 PMC: 11723797. DOI: 10.1055/a-2365-3900.

Insights into Immune Exhaustion in Chronic Hepatitis B: A Review of Checkpoint Receptor Expression.

Costa J, de Carvalho A, Paiva A, Borges O Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065812 PMC: 11279883. DOI: 10.3390/ph17070964.

STINGing Defenses: Unmasking the Mechanisms of DNA Oncovirus-Mediated Immune Escape.

Martinez-Lopez M, Muslin C, Kyriakidis N Viruses. 2024; 16(4).

PMID: 38675916 PMC: 11054469. DOI: 10.3390/v16040574.

The T-cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective role.

Bertoletti A, Tan A, Bert N Oxf Open Immunol. 2024; 2(1):iqab006.

PMID: 38626271 PMC: 7928654. DOI: 10.1093/oxfimm/iqab006.

References

Rehermann B, Ferrari C, PASQUINELLI C, Chisari F . The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med. 1996; 2(10):1104-8. DOI: 10.1038/nm1096-1104. View

Weiner A, Erickson A, Kansopon J, Crawford K, Muchmore E, Houghton M . Association of cytotoxic T lymphocyte (CTL) escape mutations with persistent hepatitis C virus (HCV) infection. Princess Takamatsu Symp. 1995; 25:227-35. View

Koike K, Moriya K, Ishibashi K, Yotsuyanagi H, Shintani Y, Fujie H . Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci U S A. 1997; 94(1):233-6. PMC: 19297. DOI: 10.1073/pnas.94.1.233. View

PASQUINELLI C, Shoenberger J, Chung J, Chang K, Guidotti L, Selby M . Hepatitis C virus core and E2 protein expression in transgenic mice. Hepatology. 1997; 25(3):719-27. DOI: 10.1002/hep.510250338. View

Carman W, Boner W, Fattovich G, Colman K, Dornan E, Thursz M . Hepatitis B virus core protein mutations are concentrated in B cell epitopes in progressive disease and in T helper cell epitopes during clinical remission. J Infect Dis. 1997; 175(5):1093-100. DOI: 10.1086/516447. View

Gale Jr M, Korth M, Tang N, Tan S, Hopkins D, Dever T . Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology. 1997; 230(2):217-27. DOI: 10.1006/viro.1997.8493. View

Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Ishibashi K, Matsuura Y . Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol. 1997; 78 ( Pt 7):1527-31. DOI: 10.1099/0022-1317-78-7-1527. View

Kaneko T, Moriyama T, Udaka K, Hiroishi K, Kita H, Okamoto H . Impaired induction of cytotoxic T lymphocytes by antagonism of a weak agonist borne by a variant hepatitis C virus epitope. Eur J Immunol. 1997; 27(7):1782-7. DOI: 10.1002/eji.1830270728. View

Franco A, Guidotti L, Hobbs M, Pasquetto V, Chisari F . Pathogenetic effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice. J Immunol. 1997; 159(4):2001-8. View

10.

Chang K, Rehermann B, McHutchison J, PASQUINELLI C, Southwood S, Sette A . Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. J Clin Invest. 1997; 100(9):2376-85. PMC: 508436. DOI: 10.1172/JCI119778. View

11.

Cavanaugh V, Guidotti L, Chisari F . Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice. J Virol. 1998; 72(4):2630-7. PMC: 109701. DOI: 10.1128/JVI.72.4.2630-2637.1998. View

12.

Wakita T, Taya C, Katsume A, Kato J, Yonekawa H, Kanegae Y . Efficient conditional transgene expression in hepatitis C virus cDNA transgenic mice mediated by the Cre/loxP system. J Biol Chem. 1998; 273(15):9001-6. DOI: 10.1074/jbc.273.15.9001. View

13.

Zhu N, Khoshnan A, Schneider R, Matsumoto M, Dennert G, Ware C . Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol. 1998; 72(5):3691-7. PMC: 109590. DOI: 10.1128/JVI.72.5.3691-3697.1998. View

14.

Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K . The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med. 1998; 4(9):1065-7. DOI: 10.1038/2053. View

15.

Tsai S, Chen Y, Chen M, Huang C, Sheen I, Yeh C . Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity. Gastroenterology. 1998; 115(4):954-65. DOI: 10.1016/s0016-5085(98)70268-9. View

16.

Stark G, Kerr I, Williams B, Silverman R, Schreiber R . How cells respond to interferons. Annu Rev Biochem. 1998; 67:227-64. DOI: 10.1146/annurev.biochem.67.1.227. View

17.

Bertoni R, Sette A, Sidney J, Guidotti L, Shapiro M, Purcell R . Human class I supertypes and CTL repertoires extend to chimpanzees. J Immunol. 1998; 161(8):4447-55. View

18.

Giuggio V, Bonkovsky H, Smith J, Rothman A . Inefficient recognition of autologous viral sequences by intrahepatic hepatitis C virus-specific cytotoxic T lymphocytes in chronically infected subjects. Virology. 1998; 251(1):132-40. DOI: 10.1006/viro.1998.9401. View

19.

Ishikawa T, Kono D, Chung J, Fowler P, Theofilopoulos A, Kakumu S . Polyclonality and multispecificity of the CTL response to a single viral epitope. J Immunol. 1998; 161(11):5842-50. View

20.

Heise T, Guidotti L, Cavanaugh V, Chisari F . Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice. J Virol. 1998; 73(1):474-81. PMC: 103854. DOI: 10.1128/JVI.73.1.474-481.1999. View